Molecular challenges imposed by MHC-I restricted long epitopes on T cell immunity

被引:27
|
作者
Josephs, Tracy M. [1 ,2 ,3 ]
Grant, Emma J. [1 ,2 ,4 ]
Gras, Stephanie [1 ,2 ,3 ]
机构
[1] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia
[2] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia
[3] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia
[4] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales
基金
澳大利亚研究理事会; 英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
antigen presentation; human leukocyte antigen; major histocompatibility complex; T cell receptor recognition; tumor peptide; viral peptide; COMPLEX CLASS-I; BULGED VIRAL PEPTIDE; HLA MICROPOLYMORPHISM; RECEPTOR RECOGNITION; IMPACT; REPERTOIRE; RESPONSES; SELF; IMMUNODOMINANCE; SPECIFICITY;
D O I
10.1515/hsz-2016-0305
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has widely been accepted that major histocompatibility complex class I molecules (MHC-I) are limited to binding small peptides of 8-10 residues in length. However, this consensus has recently been challenged with the identification of longer peptides (>= 11 residues) that can also elicit cytotoxic CD8 (+) T cell responses. Indeed, a growing number of studies demonstrate that these non-canonical epitopes are important targets for the immune system. As long epitopes represent up to 10% of the peptide repertoire bound to MHC-I molecules, here we review their impact on antigen presentation by MHC-I, TCR recognition, and T cell immunity.
引用
收藏
页码:1027 / 1036
页数:10
相关论文
共 50 条
  • [31] T-Cell Receptor Binding Affects the Dynamics of the Peptide/MHC-I Complex
    Knapp, Bernhard
    Deane, Charlotte M.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (01) : 46 - 53
  • [32] GENERATION OF MHC-I RESTRICTED CD4+CMV SPECIFIC T CELLS FOR THE MANAGEMENT OF LEUKEMIA PATIENTS
    Xue, S.
    Gao, L.
    Ghorashian, S.
    Pospori, C.
    Ahmadi, M.
    Holler, A.
    Thomas, S.
    Stauss, H. J.
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : S65 - S66
  • [33] SELECTION OF EPITOPES FOR RECOGNITION BY CLASS-I MHC-RESTRICTED CYTOTOXIC T-LYMPHOCYTES
    MILLIGAN, GN
    BRACIALE, TJ
    GAMBLE, JN
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 47 - 47
  • [34] Sticholysin II shows similar immunostimulatory properties to LLO stimulating dendritic cells and MHC-I restricted T cell responses of heterologous antigen
    del Valle, A.
    Acosta-Rivero, N.
    Laborde, R. J.
    Cruz-Leal, Y.
    Cabezas, S.
    Luzardo, M. C.
    Alvarez, C.
    Labrada, M.
    Rodriguez, A.
    Rodriguez, G. L.
    Raymond, J.
    Nogueira, C., V
    Grubaugh, D.
    Fernandez, L. E.
    Higgins, D.
    Lanio, M. E.
    TOXICON, 2021, 200 : 38 - 47
  • [35] Immunogenic CTL Epitopes Tend to be Stably Bound to MHC Class I Molecules: Implications for 'Holes in the Stably Bound MHC-I Repertoire'
    Harndahl, Mikkel
    Rasmussen, Michael
    Roder, Gustav
    Pedersen, Ida Dalgaard
    Sorensen, Mikael
    Nielsen, Morten
    Buus, Soren
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73 (04) : 353 - 353
  • [36] CD8+ T cell dialyzable extract activity is dependent on TCR and MHC-I
    Kieh, Mark D.
    Datta, Sandip K.
    Myles, Ian A.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (03) : 566 - 567
  • [37] SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses
    Agerer, Benedikt
    Koblischke, Maximilian
    Gudipati, Venugopal
    Montano-Gutierrez, Luis Fernando
    Smyth, Mark
    Popa, Alexandra
    Genger, Jakob-Wendelin
    Endler, Lukas
    Florian, David M.
    Muehlgrabner, Vanessa
    Graninger, Marianne
    Aberle, Stephan W.
    Husa, Anna-Maria
    Shaw, Lisa Ellen
    Lercher, Alexander
    Gattinger, Pia
    Torralba-Gombau, Ricard
    Trapin, Doris
    Penz, Thomas
    Barreca, Daniele
    Fae, Ingrid
    Wenda, Sabine
    Traugott, Marianna
    Walder, Gernot
    Pickl, Winfried F.
    Thiel, Volker
    Allerberger, Franz
    Stockinger, Hannes
    Puchhammer-Stoeckl, Elisabeth
    Weninger, Wolfgang
    Fischer, Gottfried
    Hoepler, Wolfgang
    Pawelka, Erich
    Zoufaly, Alexander
    Valenta, Rudolf
    Bock, Christoph
    Paster, Wolfgang
    Geyeregger, Rene
    Farlik, Matthias
    Halbritter, Florian
    Huppa, Johannes B.
    Aberle, Judith H.
    Bergthaler, Andreas
    SCIENCE IMMUNOLOGY, 2021, 6 (57)
  • [38] Genetic aberrations of NLRC5 are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma
    Gunawardana, Jay
    Lee, Justina N.
    Bednarska, Karolina
    Murigneux, Valentine
    de Long, Lilia Merida
    Sabdia, Muhammed B.
    Birch, Simone
    Tobin, Joshua W. D.
    Gandhi, Maher K.
    EJHAEM, 2020, 1 (02): : 517 - 526
  • [39] Generation of MHC-I restricted CD4+CMV and EBV specific T cells for the management of leukaemia patients
    Xue, S. A.
    Gao, L.
    Ahmadi, M.
    Ghorashian, S.
    Pospori, C.
    Holler, A.
    Thomas, S.
    Morris, E.
    Stauss, H. J.
    HUMAN GENE THERAPY, 2011, 22 (10) : A73 - A73
  • [40] In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8+ T cell response and advancement of epitope based immunotherapy for CHIKV infection
    Pratheek, B. M.
    Suryawanshi, Amol R.
    Chattopadhyay, Soma
    Chattopadhyay, Subhasis
    INFECTION GENETICS AND EVOLUTION, 2015, 31 : 118 - 126